What is Axon Therapies worth?
$44.5Mlast known valuation
Axon Therapies last raised $7.5M in its Early Stage VC (Jan 2019).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Axon Therapies
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jan 2019 | Early Stage VC | $7.5M | ▮ | ▮ |
| Jun 2017 | Seed Round | $1.3M | ▮ | ▮ |
| Apr 2016 | Seed Round | $2.0M | ▮ | ▮ |
How Axon Therapies's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Axon Therapies, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Axon Therapies worth?
- Axon Therapies's last known valuation is $44.5M.
- How much has Axon Therapies raised?
- Axon Therapies has raised $75.8M in total funding across 3 recorded rounds.
- When did Axon Therapies last raise?
- Axon Therapies last raised in Jan 2019 (Early Stage VC), raising $7.5M.